The 36th annual International Congress of German Ophthalmic Surgery (DOC) comes to Nuremberg

News
Article

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting

A cityscape of older buildings in historic Nuremberg, Germany. Image credit: ©Travel Faery – stock.adobe.com

Simultaneous translation will be available during all three days of the meeting. Image credit: ©Travel Faery – stock.adobe.com

From 20 to 22 June, the 36th International Congress of German Ophthalmic Surgery (DOC) will convene in Nuremberg, at the Nuremberg Convention Center, NCC East. Attendees can partake in a series of wetlabs, educational symposia and discussion seminars, as well as social events. Industry exhibitors will be on-site to educate practitioners about recent pharmaceutical research. During all three days of the meeting, simultaneous translation will be available in Tokio Hall at the Convention Center.

In a welcome letter, Armin Scharrer, MD, President of the DOC, addressed his colleagues1 and provided a brief preview of the programme. He said that the goal of the main symposia is to elevate the “gold standards” of eye surgery, and provide comprehensive, practice-oriented training for those in the audience.

Furthermore, Dr Scharrer spoke to the breadth and depth of topics that will be addressed in the surgical courses. “In addition to master class courses, which provide an excellent overview in a condensed form of a sub-area of ​​ophthalmology/eye surgery, the surgery courses are also continuously being expanded,” he wrote. In surgery courses, participants will undergo a step-by-step walkthrough of each surgical procedure, supplemented by best practices for postoperative care.

Video live surgery, presented this year in conjunction with the Singapore National Eye Centre, will be a significant component of the congress, Dr Scharrer wrote. The videos will showcase “modern surgical techniques in difficult initial situations,” he said.1 In other sessions, speakers will discuss and debate divisive topics in ophthalmic surgery, headed by symposium chairs. “The task of the chair of a meeting is to actively shape the controversial discussion,” Dr Scharrer said. “The subjective, personal opinion of the chair is also of interest to the audience.”

He shared a list of topics that are new for 2024, which include the following: "Sustainability in ophthalmology and eye surgery,” “artificial intelligence [AI] in ophthalmology” and the professional policy session, "Do we need more or less economy in the healthcare system in Germany?" The congress will feature several different educational opportunities in the realm of practice management. Dr Scharrer noted that the meeting is not exclusive to those with medical degrees, but also offers a comprehensive programme for ophthalmological assistants in clinics and practices.

Information about the meeting, the participant portal, digital access and a help desk can be found at the DOC website: https://www.doc-nuernberg.de/index-e.php

Reference

  1. Scharrer, A. Greetings from Dr Armin Scharrer. International Congress of German Ophthalmic Surgery. Accessed 18 June, 2024. https://www.doc-nuernberg.de/grusswort-scharrer.php

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.